Loading
₹1,929.00
−16.50−0.85%today
Market closed · 7 Oct, 3:30 pm
+41.86%over 1 year
Today's range
₹1,928.00₹1,963.70
52-week range
₹1,251.60₹2,038.00
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 9,563 | 1,141 | 11.9% | 44.98 |
| FY25 | 8,855 | 738 | 8.3% | 29.08 |
| FY24 | 7,622 | 547 | 7.2% | 21.57 |
| FY23 | 6,207 | 471 | 7.6% | 18.58 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 44.72% | 44.72% | 44.72% | 44.72% |
| FIIs | 10.73% | 10.63% | 10.63% | 10.43% |
| DIIs | 37.37% | 37.45% | 37.32% | 36.77% |
| of which mutual funds | 31.15% | 31.24% | 30.52% | 30.04% |
| Public | 7.18% | 7.20% | 7.33% | 8.07% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Biocon Ltd.BIOCON | 360.00 | −2.47% | 58,669 |
| Abbott India Ltd.ABBOTINDIA | 26,100.00 | −0.06% | 55,461 |
| Gland Pharma Ltd.GLAND | 3,159.00 | +5.09% | 52,127 |
| Anthem Biosciences Ltd.ANTHEM | 887.05 | −0.37% | 49,988 |
| Ipca Laboratories Ltd.IPCALAB · this stock | 1,929.00 | −0.85% | 48,940 |
| Ajanta Pharmaceuticals Ltd.AJANTPHARM | 3,570.00 | −0.10% | 44,610 |
| Glaxosmithkline Pharmaceuticals Ltd.GLAXO | 2,628.00 | −4.61% | 44,520 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.